“Formulation and Optimization of Liquisolid Tablet for Improving the Dissolution Profile of Rivaroxaban by Using DoE Approachand Antithrombic Activity”. 2025. Journal of Carcinogenesis 24 (3s): 812-30. https://doi.org/10.64149/J.Carcinog.24.3s.812-830.